Dana-Farber’s Dr. Elizabeth Mittendorf Wants To Harness The Immune System To Kill Breast Cancer Forever
Dr. Elizabeth Mittendorf is a Komen grantee and is working to use the immune system to kill breast cancer and prevent its return.
Research
Dana-Farber’s Dr. Nikhil Wagle Is Using Genomics to Predict a Patient’s Response to Breast Cancer Treatment
Dr. Nikhil Wagle is a Komen grantee and is using genomics to better understand why some patients respond to treatment and others do not.
Columbia University’s Dr. Neil Vasan Talks About High-Risk Research, COVID Breakthroughs
Dr. Neil Vasan is a Komen grantee and recounts some amazing opportunities and discoveries during the COIVD-19 pandemic.
Dana-Farber’s Dr. Ann Partridge Helps Young Women Thrive During and After Breast Cancer
Susan G. Komen has been deeply invested in supporting researchers at Massachusetts cancer institutions since its founding in 1982. Over the last forty years, Komen has awarded 260 grants, totaling $88 million in research, locally. Ann Partridge, M.D., M.P.H., has dedicated her career to understanding and treating breast cancer in young women. She is also […]
Weill Cornell’s Rulla Tamimi On The Importance of Diet And Breast Cancer Risk, Risk of Recurrence
Susan G. Komen has been deeply invested in supporting researchers at New York cancer institutions since its founding in 1982. Over the last forty years, Komen has awarded 209 grants, totaling $58.4 million in research, locally. Rulla Tamimi, Sc.D, professor of population health sciences at Weill Cornell Medicine, is a Susan G. Komen grantee. She […]
How Your Generosity is Funding Groundbreaking Metastatic Breast Cancer Research
For Komen Scholar Alana Welm, Ph.D., researching metastatic breast cancer (MBC) is the greatest unmet medical need in breast cancer treatment today.
Inflammatory Breast Cancer Grant Allows Two Researchers To Test A New Tool For Diagnosing The Aggressive Subtype
Inflammatory breast cancer – or IBC – is an aggressive subtype of breast cancer that often presents as a breast rash, and not a lump. It progresses rapidly and is often misdiagnosed, or diagnosis is delayed, resulting in more later-stage cases when prognosis is poorer. Susan G. Komen is awarding a $350,000 grant to Dr. […]
Studying What’s Inside Breast Tumors May Help Prevent Recurrence in Patients at Highest Risk of Relapse
Christina Curtis, Ph.D., M.S., is studying the information inside breast cancer tumors in patients at highest risk of relapse, or recurrence, to better understand which therapies will work best to treat the cancer and prevent recurrence. Curtis was named a Komen Scholar in 2020 – an advisory group of distinguished leaders in breast cancer research, […]
Expert Views: Defining Inflammatory Breast Cancer Improves Diagnosis and Outcomes
Susan G. Komen has been leading a group of patient advocates, clinicians and researchers to advance our understanding of inflammatory breast cancer.
Using Genetic Screening and Counseling to Improve Outcomes for People with Inherited Breast Cancers
Komen Scholar Dr. Tuya Pal is working to understand and develop strategies to improve outcomes for Black women, especially young Black women, through genetic testing and counseling.
Researcher Tackles Breast Cancer Disparities
To better understand breast cancer disparities, Lauren McCullough, who has a doctorate in epidemiology¸ studies factors such as race, ethnicity, socio-economics and geography. She also focuses on genetics, epigenetics and other biomarkers. The goal of her research is to improve cancer outcomes among low-income and minority women by identifying molecular targets for behavioral and therapeutic intervention.
Dedicated to Achieving Equity in Breast Cancer Care
Lori Pierce, a University of Michigan radiation oncologist and a former Komen Scholar, is committed to improving outcomes for Black women with breast cancer.